Adelaide Adjovu, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 195 Industrial Pkwy, Lyndonville, VT 05851 Phone: 802-748-9501 |
Brent Robert Braswell, FNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 195 Industrial Pkwy Ste 1, Lyndonville, VT 05851 Phone: 802-748-9501 Fax: 802-748-3420 |
Francesca Ann Berriman, P.N.P. Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 313 Juniper Ln, Lyndonville, VT 05851 Phone: 802-626-9071 |
News Archive
Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Postdoctoral fellow Brian Altman, PhD, and doctoral student Annie Hsieh, MD, both from the lab of senior author Chi Van Dang, MD, PhD, director Abramson Cancer Center, study body clock proteins associated with cancer cells.
Vulnerable persons who have not been vaccinated for measles and have been through airports in Newark, New Jersey, Detroit and Memphis this month are being warned about the possible risk of measles by the health officials. They have announced that two air passengers from overseas were confirmed to have had measles and were travelling via these airports.
For many, music is a universal language that unites people when words cannot. But for those who use cochlear implants - technology that allows deaf and hard of hearing people to comprehend speech - hearing music remains extremely challenging.
The Medicines Patent Pool, the world's only voluntary licensing mechanism in public health, announced an expansion of its mandate today to hepatitis C and tuberculosis medicines. The UNITAID Executive Board, meeting November 4-5 in Geneva, approved the MPP's proposals to improve access to both life-saving direct acting antivirals (DAAs) to treat hepatitis C and new and re-purposed medicines for tuberculosis.
Endo Pharmaceuticals has announced that it has signed two research collaboration agreements to develop novel treatments for pain and to discover potential treatments for cancer.
› Verified 3 days ago